CATALYST PHARMACEUTICALS, INC.
CPRX$2.98B
Mid CapNASDAQBiotechnology🇺🇸North America181 employees
Drugs in Pipeline
4
Phase 3 Programs
2
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
CPRX News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
vigabatrin
Cocaine Dependence
Amifampridine Phosphate
Lambert Eaton Myasthenic Syndrome
Coagulation Factor IX variant
Hemophilia B
Coagulation Factor VIIa variant
Hemophilia A With Inhibitor
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
vigabatrin | Phase 3 | Cocaine Dependence | - | - |
Amifampridine Phosphate | Phase 3 | Lambert Eaton Myasthenic Syndrome | - | - |
Coagulation Factor IX variant | Phase 2 | Hemophilia B | - | - |
Coagulation Factor VIIa variant | Phase 2 | Hemophilia A With Inhibitor | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply